NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	139.39	319.95	112.55	98.97	155.56	162.57
Short-Term Investments	438.6	294.78	362.71	344.41	292.02	259.37
Trading Asset Securities	-	-	-	50.6	50.29	50.2
Cash & Short-Term Investments	577.99	614.73	475.26	493.98	497.87	472.13
Cash Growth	17.02%	29.35%	-3.79%	-0.78%	5.45%	17.19%
Accounts Receivable	45.24	56.73	55.17	64.35	65.48	60.02
Other Receivables	0.13	1.61	1.93	-	-	0.05
Receivables	45.37	58.35	57.1	64.35	65.48	60.07
Inventory	83.39	84.37	82.5	59.56	55.8	37.71
Prepaid Expenses	12.92	-	-	4.15	-	-
Other Current Assets	0.27	13.22	12.15	0.23	4.63	5.42
Total Current Assets	719.93	770.67	627.01	622.26	623.77	575.33
Property, Plant & Equipment	5.35	3.96	8.62	3.63	8.26	5.33
Goodwill	8.54	8.54	8.54	8.54	8.54	8.54
Other Intangible Assets	19.85	22.85	28.84	33.97	38.93	43.71
Long-Term Deferred Tax Assets	25.67	28.44	20.16	19.14	19.4	18.89
Other Long-Term Assets	7.36	6.13	5.28	5.06	5.66	6.44
Total Assets	786.7	840.59	698.45	692.6	704.57	658.24
Accounts Payable	22.21	12.97	22.98	8.8	22.99	1.79
Accrued Expenses	16.43	13.54	15.43	22.41	30.53	35.28
Current Portion of Leases	2.87	3.35	4.52	2.7	3.94	2.74
Current Income Taxes Payable	7.41	8.39	0.1	0.68	1.33	0.1
Current Unearned Revenue	7.23	6.51	5.67	4.34	7.49	7.85
Other Current Liabilities	4.39	5.68	5.59	3.92	2.09	2.11
Total Current Liabilities	60.54	50.44	54.29	42.85	68.37	49.87
Long-Term Leases	1.55	0.06	3.27	-	2.7	-
Long-Term Deferred Tax Liabilities	1.97	2.54	3.33	4.24	5.15	6.06
Other Long-Term Liabilities	4	4	4	4	4	4
Total Liabilities	68.06	57.03	64.89	51.09	80.22	59.93
Common Stock	493.77	492.9	492.9	492.9	492.9	465
Additional Paid-In Capital	193.46	193.65	77.67	70.84	69.13	69.13
Retained Earnings	26.45	55.33	64.29	78.81	63.57	65.32
Comprehensive Income & Other	-2.76	-0.86	-1.29	-1.04	-1.26	-1.14
Total Common Equity	684.48	741.02	633.56	641.51	624.35	598.31
Minority Interest	34.17	42.54	-	-	-	-
Shareholders' Equity	718.64	783.56	633.56	641.51	624.35	598.31
Total Liabilities & Equity	786.7	840.59	698.45	692.6	704.57	658.24
Total Debt	4.42	3.4	7.78	2.7	6.64	2.74
Net Cash (Debt)	573.57	611.33	467.48	491.28	491.23	469.39
Net Cash Growth	17.44%	30.77%	-4.84%	0.01%	4.65%	18.51%
Net Cash Per Share	11.64	12.27	9.37	9.93	9.96	9.51
Filing Date Shares Outstanding	47	49.29	49.2	49.29	49.29	49.29
Total Common Shares Outstanding	47	49.29	49.2	49.29	49.29	49.29
Working Capital	659.39	720.23	572.72	579.42	555.41	525.46
Book Value Per Share	14.56	15.03	12.88	13.02	12.67	12.14
Tangible Book Value	656.09	709.62	596.18	599	576.88	546.06
Tangible Book Value Per Share	13.96	14.40	12.12	12.15	11.70	11.08
Machinery	8.3	7.7	7.58	7.58	7.61	7.61
Leasehold Improvements	5.19	5.19	5.19	4.88	5.08	5.08

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.